ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with 18F-FDG PET and Correlation with Genotype and GLUT4 Expression

Annick D. Van den Abbeele; Constantine Gatsonis; Daniel J. de Vries; Yulia Melenevsky; Agnieszka Szot-Barnes; Jeffrey T. Yap; Andrew K. Godwin; Lori Rink; Min Huang; Meridith Blevins; JoRean Sicks; Burton Eisenberg; Barry A. Siegel

doi:10.2967/jnumed.111.094425

Research ArticleClinical Investigations

ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with ¹⁸F-FDG PET and Correlation with Genotype and GLUT4 Expression

Annick D. Van den Abbeele, Constantine Gatsonis, Daniel J. de Vries, Yulia Melenevsky, Agnieszka Szot-Barnes, Jeffrey T. Yap, Andrew K. Godwin, Lori Rink, Min Huang, Meridith Blevins, JoRean Sicks, Burton Eisenberg and Barry A. Siegel

Journal of Nuclear Medicine April 2012, 53 (4) 567-574; DOI: https://doi.org/10.2967/jnumed.111.094425

Annick D. Van den Abbeele

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Constantine Gatsonis

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel J. de Vries

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yulia Melenevsky

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Agnieszka Szot-Barnes

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeffrey T. Yap

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrew K. Godwin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lori Rink

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Min Huang

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Meridith Blevins

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

JoRean Sicks

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Burton Eisenberg

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Barry A. Siegel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 53, Issue 4

April 1, 2012

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with 18F-FDG PET and Correlation with Genotype and GLUT4 Expression

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with ¹⁸F-FDG PET and Correlation with Genotype and GLUT4 Expression

Journal of Nuclear Medicine Apr 2012, 53 (4) 567-574; DOI: 10.2967/jnumed.111.094425

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Journal of Nuclear Medicine Apr 2012, 53 (4) 567-574; DOI: 10.2967/jnumed.111.094425

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial
Imaging-Based Treatment Adaptation in Radiation Oncology
PDT with a Glucose-Conjugated Chlorin for GIST--Response
Imaging of Platelet-Derived Growth Factor Receptor {beta} Expression in Glioblastoma Xenografts Using Affibody Molecule 111In-DOTA-Z09591

Google Scholar

Main menu

User menu

Search

ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with ¹⁸F-FDG PET and Correlation with Genotype and GLUT4 Expression

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles